News & updates

Janssen COVID-19 vaccine approved for use in EU on March 11

Created on:

March 11, 2021

The Janssen-Cilag International N.V COVID-19 vaccine has received authorization for emergency use by the European Medicines Agency (EMA) on March 11. Developed with fundamental support from the Molecular Virology group of the Leiden University Medical Centre (LUMC), it is the fourth vaccine to be administered in the European Union. The Netherlands has ordered more than 11 million vaccine doses.

Janssen first approached the LUMC Molecular Virology group in February of 2020. “A collaboration to support the development of the Janssen COVID-19 vaccine was proposed because they knew we had been studying coronaviruses for over 30 years”, says Professor Eric Snijder of the LUMC department of Medical Microbiology. Together, Snijder and Dr Marjolein Kikkert were responsible for leading the project. Snijder emphasizes that they were able to rapidly assist with the first phase of vaccine development and testing due to LUMC’s well-established research infrastructure: “not only did we have the experience, but we also had trained staff available and a state-of-the-art Biosafety Level 3 (BSL-3) laboratory”.

Read the full article

More news & updates

Join the Indonesian WINNER Event 26-28 October, 2021

October 12, 2021

This WINNER (Week of Indonesia Netherlands Education and Research) event is a follow-up of the Climate Adaptation Summit (CAS), January 2021, and explores forms of cooperation between and within nations to make climate adaptation work for everyone, with a focus on Indonesia and the Netherlands. We will build on the successful international establishment of the Adaptation Action Agenda with high level keynotes. Then, two forms of Indonesia – Netherlands collaboration in urban and rural areas will be highlighted. Finally, we dive into the prerequisites for successful climate adaptation in a session focused on a priority for both the Netherlands and Indonesia: water resilience.

Improving maternal care in Ethiopia through PhD collaboration between Universities of Oxford, Haramaya and the LUMC

June 20, 2023

Sagni Girma Fage and Mohammed Yuya Ebro, two LUMC Global PhD students, are busy conducting research in eastern Ethiopia through a project called “Ethiopian Obstetric Surveillance System (EthOSS)”. This is a collaboration between Haramaya University (Ethiopia), the University of Oxford (UK), and LUMC which is active in 13 public hospitals in eastern Ethiopia. They are trying to identify determinants of maternal death such as perinatal hemorrhage in order to develop and implement new interventions to prevent future maternal deaths.

Crowd in front of Rotterdam Central Station

Population Health Management (MSc)

March 17, 2021

Today’s health care system faces many challenges. The new interdisciplinary two years master PHM will train you to contribute to a more integrated health care system.

What does this master’s programme entail?

Health care faces ageing populations, rising health care costs, fragmented health care supply and advancing medical technologies and IT systems. Health care professionals will require new competences to meet these challenges in the current health care system. Population Health Management (PHM) is a broadly based response to the challenges and has emerged worldwide as an important strategy for health care